The Manila Times

Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will present new data ...
PharmiWeb

Urology Devices Market Growth - Market Analysis, Size, Share, Trends, Demand, Overview and Segment Forecast To 2029

Global Urology Devices Market OverviewThe global urology devices market is poised for steady expansion and is projected to grow at a CAGR of approximately 6–7% during the forecast period from 2024 to ...

Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate

U.S. FDA Fast Track designation granted to AKY-11891 for the treatment of adult patients with locally advanced or metastatic urothelial cancer ...

AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsTryn Stimart - Chief Legal Officer, CCO, ...

AbCellera Biologics Q4 Earnings Call Highlights

AbCellera Biologics (NASDAQ:ABCL) used its full-year 2025 business update call to emphasize that it has completed its ...

ORBIS Production Launches ‘ONE PO. WHOLE ITALY.’—A Single-PO, Full-Service Production Model Across Italy

For teams searching for a film and video production company in Italy, a photo production company in Italy, or a production service company in Italy, “ONE PO. WHOLE ITALY.” is designed as a ...

Myriad Genetics, Inc.: Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

Highlights Fourth quarter 2025 revenue of $209.8 million was consistent with fourth quarter 2024 revenue, but grew 4% year-over-year when excluding the previously discussed headwind1 of $8.1 million.F ...